Antimicrobial Treatment of <i>Staphylococcus aureus</i> Biofilms

<i>Staphylococcus aureus</i> is a microorganism frequently associated with implant-related infections, owing to its ability to produce biofilms. These infections are difficult to treat because antimicrobials must cross the biofilm to effectively inhibit bacterial growth. Although some an...

Full description

Bibliographic Details
Main Authors: Felipe Francisco Tuon, Paula Hansen Suss, Joao Paulo Telles, Leticia Ramos Dantas, Nícolas Henrique Borges, Victoria Stadler Tasca Ribeiro
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/12/1/87
_version_ 1797446978811985920
author Felipe Francisco Tuon
Paula Hansen Suss
Joao Paulo Telles
Leticia Ramos Dantas
Nícolas Henrique Borges
Victoria Stadler Tasca Ribeiro
author_facet Felipe Francisco Tuon
Paula Hansen Suss
Joao Paulo Telles
Leticia Ramos Dantas
Nícolas Henrique Borges
Victoria Stadler Tasca Ribeiro
author_sort Felipe Francisco Tuon
collection DOAJ
description <i>Staphylococcus aureus</i> is a microorganism frequently associated with implant-related infections, owing to its ability to produce biofilms. These infections are difficult to treat because antimicrobials must cross the biofilm to effectively inhibit bacterial growth. Although some antibiotics can penetrate the biofilm and reduce the bacterial load, it is important to understand that the results of routine sensitivity tests are not always valid for interpreting the activity of different drugs. In this review, a broad discussion on the genes involved in biofilm formation, quorum sensing, and antimicrobial activity in monotherapy and combination therapy is presented that should benefit researchers engaged in optimizing the treatment of infections associated with <i>S. aureus</i> biofilms.
first_indexed 2024-03-09T13:48:19Z
format Article
id doaj.art-9848f8fb03d641ab948965de50662746
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-09T13:48:19Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-9848f8fb03d641ab948965de506627462023-11-30T20:55:31ZengMDPI AGAntibiotics2079-63822023-01-011218710.3390/antibiotics12010087Antimicrobial Treatment of <i>Staphylococcus aureus</i> BiofilmsFelipe Francisco Tuon0Paula Hansen Suss1Joao Paulo Telles2Leticia Ramos Dantas3Nícolas Henrique Borges4Victoria Stadler Tasca Ribeiro5Laboratory of Emerging Infectious Diseases, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Paraná, BrazilLaboratory of Emerging Infectious Diseases, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Paraná, BrazilAC Camargo Cancer Center, Infectious Diseases Department, São Paulo 01525-001, São Paulo, BrazilLaboratory of Emerging Infectious Diseases, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Paraná, BrazilLaboratory of Emerging Infectious Diseases, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Paraná, BrazilLaboratory of Emerging Infectious Diseases, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Paraná, Brazil<i>Staphylococcus aureus</i> is a microorganism frequently associated with implant-related infections, owing to its ability to produce biofilms. These infections are difficult to treat because antimicrobials must cross the biofilm to effectively inhibit bacterial growth. Although some antibiotics can penetrate the biofilm and reduce the bacterial load, it is important to understand that the results of routine sensitivity tests are not always valid for interpreting the activity of different drugs. In this review, a broad discussion on the genes involved in biofilm formation, quorum sensing, and antimicrobial activity in monotherapy and combination therapy is presented that should benefit researchers engaged in optimizing the treatment of infections associated with <i>S. aureus</i> biofilms.https://www.mdpi.com/2079-6382/12/1/87antibioticbiofilminfections<i>Staphylococcus aureus</i>therapeutic antibiofilm
spellingShingle Felipe Francisco Tuon
Paula Hansen Suss
Joao Paulo Telles
Leticia Ramos Dantas
Nícolas Henrique Borges
Victoria Stadler Tasca Ribeiro
Antimicrobial Treatment of <i>Staphylococcus aureus</i> Biofilms
Antibiotics
antibiotic
biofilm
infections
<i>Staphylococcus aureus</i>
therapeutic antibiofilm
title Antimicrobial Treatment of <i>Staphylococcus aureus</i> Biofilms
title_full Antimicrobial Treatment of <i>Staphylococcus aureus</i> Biofilms
title_fullStr Antimicrobial Treatment of <i>Staphylococcus aureus</i> Biofilms
title_full_unstemmed Antimicrobial Treatment of <i>Staphylococcus aureus</i> Biofilms
title_short Antimicrobial Treatment of <i>Staphylococcus aureus</i> Biofilms
title_sort antimicrobial treatment of i staphylococcus aureus i biofilms
topic antibiotic
biofilm
infections
<i>Staphylococcus aureus</i>
therapeutic antibiofilm
url https://www.mdpi.com/2079-6382/12/1/87
work_keys_str_mv AT felipefranciscotuon antimicrobialtreatmentofistaphylococcusaureusibiofilms
AT paulahansensuss antimicrobialtreatmentofistaphylococcusaureusibiofilms
AT joaopaulotelles antimicrobialtreatmentofistaphylococcusaureusibiofilms
AT leticiaramosdantas antimicrobialtreatmentofistaphylococcusaureusibiofilms
AT nicolashenriqueborges antimicrobialtreatmentofistaphylococcusaureusibiofilms
AT victoriastadlertascaribeiro antimicrobialtreatmentofistaphylococcusaureusibiofilms